COMP <GO>
CBT vs SCCO // GROSS PROFIT MARGIN
Cabot Corporation (NYSE) VS. Southern Copper Corporation (NYSE) • 15-METRIC TALLY: CBT 4
— SCCO 8
▲ GROSS PROFIT MARGIN LEADER: SCCO
LAST: $73.85 (+0.11%) • MKT CAP: $3.81B
gross-margins
25.30%
LAST: $191.75 (-1.11%) • MKT CAP: $161.89B
gross-margins
60.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CBT VS. SCCO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CBT | SCCO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 25.30% | 60.10% | -34.80 | SCCO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 22.30% | 41.00% | -18.70 | SCCO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.2x | 20.2x | -15.00 | CBT | /valuation <GO> |
| Free Cash Flow Yield | 10.25% | 2.12% | +8.13 | CBT | /fcf-yield <GO> |
| Operating Margin | 16.70% | 52.20% | -35.50 | SCCO | /operating-margins <GO> |
| Net Profit Margin | 8.90% | 32.30% | -23.40 | SCCO | /net-margins <GO> |
| Revenue Growth (YoY) | -7.00% | 17.40% | -24.40 | SCCO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.52% | 1.54% | +0.98 | CBT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 11.90 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | SCCO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.4 | 47.0 | -3.64 | SCCO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.16 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.7x | 31.3x | -20.60 | CBT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.81B | $161.89B | -$158.08B | SCCO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CBT REV | SCCO REV | CBT GROSS % | SCCO GROSS % | CBT FCF | SCCO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.71B | $13.42B | 25.3% | 60.1% | $391.0M | $3.43B |
| FY 2024 | $3.99B | $11.43B | 24.0% | 57.7% | $451.0M | $3.39B |
| FY 2023 | $3.93B | $9.90B | — | — | $595.0M | $3.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CBT // BETA —
SCCO // BETA 1.16